CRYORTH CO., LTD.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
CRYORTH’s core product portfolio includes: the Freezing Tank, a cryosurgical device designed for biological reconstruction without the need for osteotomy; Cryo-Gel, a novel cryogen medium for treating residual tumor cells in aggressive bone tumors or bone
The content above was translated by Ai
Founded Year
2020
Unified Business No.
83506504
Status
Closed
Number of Employees
0
Total Paid-in
Capital
- (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
CRYORTH BioMed is a Taiwan‑based medical device company that specializes in cryosurgical solutions for musculoskeletal tumors, such as bone sarcomas. Founded by a multidisciplinary team consisting of clinical orthopedic surgeons, biomedical engineers, and regulatory experts, the company is dedicated to developing advanced and safe cryotherapy tools that enhance surgical outcomes and patient recovery.
The content above was translated by Ai
